Budget Impact Analysis of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece

Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.440
https://www.valueinhealthjournal.com/article/S1098-3015(17)30774-X/fulltext
Section Title : Disease-Specific Studies
Section Order : 414
First Page : A476
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30774-X&doi=10.1016/j.jval.2017.08.440
HEOR Topics :
Tags :
Regions :